Thinking of Buying Merit Medical Systems (MMSI)? Here's What You Need to Know.

Shares of Health Care sector company Merit Medical Systems moved 0.7% today, and are now trading at a price of $68.61. The mid-cap stock's daily volume was 11,997 compared to its average volume of 350,065. The S&P 500 index returned a 1.0% performance.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company is based in South Jordan and has 6,846 full time employees. Its market capitalization is $3,954,364,928.

8 analysts are following Merit Medical Systems and have set target prices ranging from $70.0 to $102.0 per share. On average, they have given the company a rating of buy. At today's prices, MMSI is trading -23.45% away from its average analyst target price of $89.63 per share.

Over the last year, MMSI's share price has increased by 22.0%, which represents a difference of -1.0% when compared to the S&P 500. The stock's 52 week high is $85.62 per share whereas its 52 week low is $54.66.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023-02-24 114,291 -48,139 162,430 -8.21
2022-03-01 147,231 -29,736 176,967 -17.5
2021-03-01 165,270 -49,234 214,504 35.43
2020-03-02 77,813 -80,577 158,390 3.65
2019-03-01 86,533 -66,281 152,814 47.07
2018-03-01 62,727 -41,179 103,906
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.